PMID- 28429502 OWN - NLM STAT- MEDLINE DCOM- 20180321 LR - 20180321 IS - 1440-1681 (Electronic) IS - 0305-1870 (Linking) VI - 44 IP - 7 DP - 2017 Jul TI - Involvement of ERK1/2 in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes. PG - 771-778 LID - 10.1111/1440-1681.12766 [doi] AB - Connexin 43 (Cx43) plays an important role in the pathogenesis of atrial fibrillation (AF). The present study sought to investigate the effect of macrophage migration inhibitory factor (MIF), a pleiotropic cytokine, on Cx43 expression and activity and determine the intracellular signalling pathways. Cx43 protein and mRNA levels were assayed using immunofluorescence, real-time polymerase chain reaction (PCR), and western blot. We found that increased MIF and extracellular regulated protein kinases (ERK) expression was accompanied by a significant reduction in Cx43 protein expression in atrial tissues from patients with AF compared with those with sinus rhythm. In cultured atrium-derived myocytes (HL-1 cells), mouse recombinant-MIF (rMIF, 20 or 40 nmol/L, 24 hours) down-regulated gene and protein expression of Cx43 in a concentration-dependent manner. U0126, a specific inhibitor of mitogen-activated protein kinase kinase (MAPKK) could reverse the decrease in expression of Cx43 protein induced by rMIF. Further studies revealed that rMIF (40 nmol/L, 15, 30, and 45 minutes) was able to stimulate phospho-Erk1/2 (Thr202/Tyr204) production in a time-dependent manner. These results suggest that MIF is involved in the pathogenesis of AF, probably by down-regulating the protein and gene expression of Cx43 via ERK1/2 kinase activation. Our findings represent a potential pathogenic mechanism in AF. CI - (c) 2017 John Wiley & Sons Australia, Ltd. FAU - Li, Xin AU - Li X AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Rao, Fang AU - Rao F AUID- ORCID: 0000-0002-1181-2333 AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. FAU - Deng, Chun-Yu AU - Deng CY AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. FAU - Wei, Wei AU - Wei W AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Liu, Fang-Zhou AU - Liu FZ AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Yang, Hui AU - Yang H AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. FAU - Wang, Zhao-Yu AU - Wang ZY AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Kuang, Su-Juan AU - Kuang SJ AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. FAU - Chen, Xiao-Yan AU - Chen XY AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. FAU - Xue, Yu-Mei AU - Xue YM AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. FAU - Wu, Shu-Lin AU - Wu SL AUID- ORCID: 0000-0002-6378-2009 AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. AD - Guangdong Academy of Medical Sciences, Guangzhou, China. AD - Research Center of Medical Sciences, Guangdong General Hospital, Guangzhou, China. LA - eng PT - Journal Article PL - Australia TA - Clin Exp Pharmacol Physiol JT - Clinical and experimental pharmacology & physiology JID - 0425076 RN - 0 (Connexin 43) RN - 0 (Macrophage Migration-Inhibitory Factors) RN - 0 (Protein Kinase Inhibitors) RN - 0 (RNA, Messenger) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) SB - IM MH - Adult MH - Animals MH - Atrial Fibrillation/genetics/metabolism/pathology MH - Connexin 43/genetics/*metabolism MH - Female MH - Gene Expression Regulation, Enzymologic/drug effects MH - Heart Atria/*cytology/pathology MH - Humans MH - Macrophage Migration-Inhibitory Factors/*metabolism/pharmacology MH - Male MH - Mice MH - Middle Aged MH - Mitogen-Activated Protein Kinase 1/*metabolism MH - Mitogen-Activated Protein Kinase 3/*metabolism MH - Myocytes, Cardiac/cytology/*metabolism/pathology MH - Protein Kinase Inhibitors/pharmacology MH - RNA, Messenger/genetics/metabolism MH - Signal Transduction/drug effects MH - Sinoatrial Node/drug effects/physiology/physiopathology OTO - NOTNLM OT - ERK1/2 OT - atrial fibrillation OT - connexin 43 OT - macrophage migration inhibitory factor EDAT- 2017/04/22 06:00 MHDA- 2018/03/22 06:00 CRDT- 2017/04/22 06:00 PHST- 2016/11/22 00:00 [received] PHST- 2017/03/19 00:00 [revised] PHST- 2017/03/31 00:00 [accepted] PHST- 2017/04/22 06:00 [pubmed] PHST- 2018/03/22 06:00 [medline] PHST- 2017/04/22 06:00 [entrez] AID - 10.1111/1440-1681.12766 [doi] PST - ppublish SO - Clin Exp Pharmacol Physiol. 2017 Jul;44(7):771-778. doi: 10.1111/1440-1681.12766.